Bharat Biotech to pump Rs 100 crore on the setup of new facility

Bharat Biotech International LtdBharat Biotech International Ltd (BBIL), the largest manufacturer of Hepatitis-B vaccines, is presently in the process of setting up Rs 100-crore unit near Bangalore that will manufacture 100 million doses of animal vaccines.

The new unit is expected to be commissioned in two months, which will have a production capacity of 100 million doses of vaccine for cattle and other animals.

According to the sources, the main product of the new venture will be called as BIO-VET International Limited, which would be a vaccine for the foot and mouth disease prevalent among cattle.

The company is eyeing a business turnover of over Rs 400 crore in the current fiscal compared to Rs 300 crore in 2008-09.